Mackay Shields LLC’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Mackay Shields LLC's DGX Position: Q2 2022 in Review
Mackay Shields LLC sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 17,282 shares — an estimated $2.37M sold.
Mackay Shields LLC first reported a position in DGX in Q1 2018 and held it in 17 quarters. The position peaked at $3.69M in Q4 2020. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Mackay Shields LLC reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- Mackay Shields LLC sold 17,282 Quest Diagnostics shares in Q2 2022, an estimated $2.37M.
- Mackay Shields LLC first reported a position in Quest Diagnostics in Q1 2018 and held it in 17 quarters.
- Mackay Shields LLC's Quest Diagnostics position peaked at $3.69M in Q4 2020.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.